- Home
- KNX vs EXEL Comparison
KNX vs EXEL Comparison
Compare KNX & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNX
- EXEL
- Stock Information
- Founded
- KNX 1989
- EXEL 1994
- Country
- KNX United States
- EXEL United States
- Employees
- KNX N/A
- EXEL N/A
- Industry
- KNX Trucking Freight/Courier Services
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KNX Industrials
- EXEL Health Care
- Exchange
- KNX Nasdaq
- EXEL Nasdaq
- Market Cap
- KNX 9.6B
- EXEL 10.0B
- IPO Year
- KNX 1994
- EXEL 2000
- Fundamental
- Price
- KNX $51.98
- EXEL $33.29
- Analyst Decision
- KNX Buy
- EXEL Buy
- Analyst Count
- KNX 17
- EXEL 16
- Target Price
- KNX $57.00
- EXEL $32.75
- AVG Volume (30 Days)
- KNX 1.9M
- EXEL 2.1M
- Earning Date
- KNX 01-22-2025
- EXEL 02-04-2025
- Dividend Yield
- KNX 1.23%
- EXEL N/A
- EPS Growth
- KNX N/A
- EXEL 441.02
- EPS
- KNX 0.23
- EXEL 1.55
- Revenue
- KNX $7,477,716,000.00
- EXEL $2,081,598,000.00
- Revenue This Year
- KNX $5.11
- EXEL $20.59
- Revenue Next Year
- KNX $5.98
- EXEL $1.50
- P/E Ratio
- KNX $225.31
- EXEL $21.51
- Revenue Growth
- KNX 7.54
- EXEL 17.31
- 52 Week Low
- KNX $45.55
- EXEL $19.20
- 52 Week High
- KNX $60.99
- EXEL $36.97
- Technical
- Relative Strength Index (RSI)
- KNX 32.25
- EXEL 40.46
- Support Level
- KNX $55.40
- EXEL $34.58
- Resistance Level
- KNX $57.55
- EXEL $36.22
- Average True Range (ATR)
- KNX 1.41
- EXEL 0.80
- MACD
- KNX -0.67
- EXEL -0.44
- Stochastic Oscillator
- KNX 9.76
- EXEL 5.79
About KNX Knight-Swift Transportation Holdings Inc.
Knight-Swift is the largest truckload carrier in the US, with a diversified transportation offering. Pro forma for the U.S. Xpress deal, about 82% of revenue derives from Knight's asset-based trucking business, with full truckload (for-hire dry van, refrigerated, and dedicated contract) making up 69% and less than truckload at 13%. Truck brokerage and other asset-light logistics services make up 9% of revenue, with intermodal near 6%. Knight's intermodal operations use the Class I railroads for the underlying movement of its shipping containers and include drayage (regional trucking services to and from inland intermodal ramps/terminals). The remainder of revenue reflects services offered to shippers and third-party truckers, including equipment maintenance and leasing.
About EXEL Exelixis Inc.
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.